ArticleFrontiers in medicine2022
Diabetic Retinopathy Grading by Deep Graph Correlation Network on Retinal Images Without Manual Annotations.
Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Trends and hotspots in the field of diabetic retinopathy imaging research from 2000-2023.Frontiers in medicine · 2024Pooled it
- An explainable ensemble for diabetic retinopathy grading with a novel confidence quality factor and configurable heatmaps.Medical & biological engineering & computing · 2026Article
- Graph-enhanced deep learning for diabetic retinopathy diagnosis: A quality-aware and uncertainty-driven approach.PLoS computational biology · 2025Article
- Self-supervised based clustering for retinal optical coherence tomography images.Eye (London, England) · 2025Article
- Exploring the effect of gestational diabetes mellitus on retinal vascular morphology by PKSEA-Net.Frontiers in cell and developmental biology · 2024Article
- Color fundus photograph-based diabetic retinopathy grading via label relaxed collaborative learning on deep features and radiomics features.Frontiers in cell and developmental biology · 2024Article
- A multidomain bio-inspired feature extraction and selection model for diabetic retinopathy severity classification: an ensemble learning approach.Scientific reports · 2023Article
- Dynamic Graph Clustering Learning for Unsupervised Diabetic Retinopathy Classification.Diagnostics (Basel, Switzerland) · 2023Article
- Research progress in artificial intelligence assisted diabetic retinopathy diagnosis.International journal of ophthalmology · 2023Article
- Research progress on diagnosing retinal vascular diseases based on artificial intelligence and fundus images.Frontiers in cell and developmental biology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic retinopathy, as a severe public health problem associated with vision loss, should be diagnosed early using an accurate screening tool. While many previous deep learning models have been proposed for this disease, they need sufficient professional annotation data to train the model, requiring more expensive and time-consuming screening skills. Method: This study aims to economize manual power and proposes a deep graph correlation network (DGCN) to develop automated diabetic retinopathy grading without any professional annotations. DGCN involves the novel deep learning algorithm of a graph convolutional network to exploit inherent correlations from independent retinal image features learned by a convolutional neural network. Three designed loss functions of graph-center, pseudo-contrastive, and transformation-invariant constrain the optimisation and application of the DGCN model in an automated diabetic retinopathy grading task. Results: To evaluate the DGCN model, this study employed EyePACS-1 and Messidor-2 sets to perform grading results. It achieved an accuracy of 89.9% (91.8%), sensitivity of 88.2% (90.2%), and specificity of 91.3% (93.0%) on EyePACS-1 (Messidor-2) data set with a confidence index of 95% and commendable effectiveness on receiver operating characteristic (ROC) curve and t-SNE plots. Conclusion: The grading capability of this study is close to that of retina specialists, but superior to that of trained graders, which demonstrates that the proposed DGCN provides an innovative route for automated diabetic retinopathy grading and other computer-aided diagnostic systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.